Kolexia
Boyle Helen
Oncologie médicale
Centre Léon-Bérard
Lyon, France
127 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Tumeurs du rein Tumeurs embryonnaires et germinales Tumeurs du testicule Métastase tumorale Seconde tumeur primitive Tumeurs de la prostate Tumeurs de la vessie urinaire

Industries

Ipsen
4 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2022
AstraZeneca
1 collaboration(s)
Dernière en 2022

Dernières activités

PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Direct-to-participant recruitment of mothers and infants: A strategic approach during challenging pandemic times.
Contemporary clinical trials communications   17 janvier 2024
Parental occupations at birth and risk of adult testicular germ cell tumors in offspring: a French nationwide case-control study.
Frontiers in public health   16 janvier 2024
ESTABLISHMENT OF END-OF-TREATMENT DAY HOSPITAL FOR ADOLESCENTS AND YOUNG ADULTS WITH CANCER
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
PASCA: Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma.
Pharmaceuticals (Basel, Switzerland)   12 juillet 2023
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network.
Journal of clinical and translational science   25 mai 2023
Testicular germ cell tumour risk by occupation and industry: a French case-control study - TESTIS.
Occupational and environmental medicine   25 mai 2023
Spécificités cliniques des tumeurs de vessie n’infiltrant pas le muscle métastatique d’emblée : étude observationnelle multicentrique merinos
116e congrès français d'urologie   01 novembre 2022